Clovis Oncology, Inc. (CLVS) Is At $62.34 Formed Wedge; Canyon Capital Advisors Decreased Its Santander Consumer Usa Hdg I (SC) Stake

Clovis Oncology, Inc. (CLVS) formed wedge down with $57.98 target or 7.00% below today’s $62.34 share price. Clovis Oncology, Inc. (CLVS) has $3.15B valuation. The stock increased 0.35% or $0.22 during the last trading session, reaching $62.34. About 558,621 shares traded. Clovis Oncology, Inc. (NASDAQ:CLVS) has risen 282.71% since March 13, 2017 and is uptrending. It has outperformed by 266.01% the S&P500.

Canyon Capital Advisors Llc decreased Santander Consumer Usa Hdg I (SC) stake by 9.18% reported in 2017Q3 SEC filing. Canyon Capital Advisors Llc sold 280,531 shares as Santander Consumer Usa Hdg I (SC)’s stock declined 16.81%. The Canyon Capital Advisors Llc holds 2.78M shares with $42.68M value, down from 3.06 million last quarter. Santander Consumer Usa Hdg I now has $6.26 billion valuation. The stock increased 0.23% or $0.04 during the last trading session, reaching $17.35. About 1.21 million shares traded. Santander Consumer USA Holdings Inc. (NYSE:SC) has risen 1.54% since March 13, 2017 and is uptrending. It has underperformed by 15.16% the S&P500.

Canyon Capital Advisors Llc increased Plains Gp Hldgs LP stake by 758,000 shares to 2.12 million valued at $46.45 million in 2017Q3. It also upped Rite Aid Corp (NYSE:RAD) stake by 1.52 million shares and now owns 2.00M shares. Mgm Resorts International (NYSE:MGM) was raised too.

Among 25 analysts covering Santander Consumer USA Holdings (NYSE:SC), 13 have Buy rating, 0 Sell and 12 Hold. Therefore 52% are positive. Santander Consumer USA Holdings had 63 analyst reports since August 3, 2015 according to SRatingsIntel. The stock of Santander Consumer USA Holdings Inc. (NYSE:SC) earned “Buy” rating by Citigroup on Friday, April 1. The rating was initiated by Janney Capital with “Neutral” on Thursday, April 21. The firm earned “Equal-Weight” rating on Tuesday, December 20 by Morgan Stanley. The stock of Santander Consumer USA Holdings Inc. (NYSE:SC) has “Hold” rating given on Thursday, February 1 by Stephens. On Wednesday, January 31 the stock rating was maintained by RBC Capital Markets with “Hold”. The stock of Santander Consumer USA Holdings Inc. (NYSE:SC) has “Overweight” rating given on Friday, January 12 by JP Morgan. As per Thursday, April 28, the company rating was maintained by Compass Point. The company was maintained on Wednesday, January 10 by Jefferies. The stock has “Neutral” rating by Susquehanna on Monday, January 23. Jefferies maintained it with “Buy” rating and $18 target in Monday, May 15 report.

Analysts await Santander Consumer USA Holdings Inc. (NYSE:SC) to report earnings on April, 25. They expect $0.42 earnings per share, up 5.00% or $0.02 from last year’s $0.4 per share. SC’s profit will be $151.47 million for 10.33 P/E if the $0.42 EPS becomes a reality. After $0.27 actual earnings per share reported by Santander Consumer USA Holdings Inc. for the previous quarter, Wall Street now forecasts 55.56% EPS growth.

Investors sentiment increased to 1.86 in Q3 2017. Its up 0.68, from 1.18 in 2017Q2. It is positive, as 25 investors sold SC shares while 42 reduced holdings. 29 funds opened positions while 50 raised stakes. 113.25 million shares or 0.98% more from 112.15 million shares in 2017Q2 were reported. Savings Bank Of Mellon Corp stated it has 937,282 shares. Bluemountain Management Limited Company reported 236,022 shares. Morgan Stanley has invested 0% in Santander Consumer USA Holdings Inc. (NYSE:SC). Adage Capital Prtn Limited Liability Com reported 450,000 shares. Quinn Opportunity Prtn Ltd Liability Co accumulated 0.03% or 14,000 shares. First Quadrant LP Ca, a California-based fund reported 615 shares. Balyasny Asset Mngmt Ltd Limited Liability Company owns 0.07% invested in Santander Consumer USA Holdings Inc. (NYSE:SC) for 1.14M shares. Jacobs Levy Equity Mgmt stated it has 64,500 shares. State Board Of Administration Of Florida Retirement System has invested 0% in Santander Consumer USA Holdings Inc. (NYSE:SC). Thrivent Financial For Lutherans holds 1.38M shares. Continental Advsr Ltd Liability holds 1.67% in Santander Consumer USA Holdings Inc. (NYSE:SC) or 474,081 shares. Products Prtnrs Limited Liability Corporation owns 0.05% invested in Santander Consumer USA Holdings Inc. (NYSE:SC) for 103,125 shares. Hotchkis And Wiley Cap Mgmt Llc has 0.21% invested in Santander Consumer USA Holdings Inc. (NYSE:SC). Metropolitan Life Insurance Communications Ny accumulated 0% or 4,428 shares. 900,292 were accumulated by Northern Tru.

Investors sentiment decreased to 1.05 in 2017 Q3. Its down 0.39, from 1.44 in 2017Q2. It is negative, as 48 investors sold Clovis Oncology, Inc. shares while 49 reduced holdings. 42 funds opened positions while 98 raised stakes. 47.46 million shares or 2.14% more from 46.46 million shares in 2017Q2 were reported. Credit Suisse Ag invested 0.02% of its portfolio in Clovis Oncology, Inc. (NASDAQ:CLVS). New York-based Mufg Americas Hldg has invested 0% in Clovis Oncology, Inc. (NASDAQ:CLVS). Amalgamated Savings Bank, a New York-based fund reported 5,587 shares. 499,688 are owned by Balyasny Asset Mngmt Ltd Liability. Jasper Ridge Prtn L P owns 9,184 shares for 0.04% of their portfolio. Swiss State Bank reported 0.01% of its portfolio in Clovis Oncology, Inc. (NASDAQ:CLVS). Eam Ltd Liability holds 0.33% or 30,073 shares in its portfolio. Jennison Assocs Lc holds 600,169 shares. Nj State Employees Deferred Compensation Plan stated it has 0.13% in Clovis Oncology, Inc. (NASDAQ:CLVS). C World Wide Grp Hldgs A S holds 0.25% of its portfolio in Clovis Oncology, Inc. (NASDAQ:CLVS) for 210,627 shares. Sivik Health Limited invested in 30,000 shares. Cypress Cap Management Ltd Liability Corporation (Wy) reported 0.2% of its portfolio in Clovis Oncology, Inc. (NASDAQ:CLVS). Credit Agricole S A invested in 19,500 shares. Savings Bank Of Montreal Can has 0% invested in Clovis Oncology, Inc. (NASDAQ:CLVS). 7,967 are held by Prelude Capital Ltd Liability Co.

Since September 15, 2017, it had 0 buys, and 8 insider sales for $1.83 million activity. $253,620 worth of Clovis Oncology, Inc. (NASDAQ:CLVS) was sold by IVERS-READ GILLIAN C. SPICKSCHEN THORLEF had sold 4,500 shares worth $270,000 on Thursday, February 22.

Among 20 analysts covering Clovis Oncology (NASDAQ:CLVS), 16 have Buy rating, 0 Sell and 4 Hold. Therefore 80% are positive. Clovis Oncology has $134 highest and $15 lowest target. $69.22’s average target is 11.04% above currents $62.34 stock price. Clovis Oncology had 61 analyst reports since September 10, 2015 according to SRatingsIntel. Suntrust Robinson initiated the shares of CLVS in report on Friday, August 5 with “Buy” rating. As per Thursday, January 26, the company rating was upgraded by Piper Jaffray. Credit Suisse maintained it with “Buy” rating and $86.0 target in Thursday, January 18 report. The rating was maintained by Mizuho on Monday, January 25 with “Neutral”. The firm has “Overweight” rating given on Wednesday, May 17 by JP Morgan. The firm earned “Outperform” rating on Thursday, February 22 by RBC Capital Markets. The firm has “Buy” rating by Leerink Swann given on Monday, July 31. As per Tuesday, November 17, the company rating was downgraded by Goldman Sachs. Suntrust Robinson maintained Clovis Oncology, Inc. (NASDAQ:CLVS) rating on Wednesday, August 24. Suntrust Robinson has “Buy” rating and $30 target. The stock has “Buy” rating by Leerink Swann on Monday, February 5.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: